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Abstract
The field of inflammatory arthritis owes 
much to the advances in imaging tech-
nology which have enlightened not only 
clinical specialists but also researchers 
worldwide. The most exciting develop-
ments in recent decades have centred 
upon rheumatoid arthritis (RA) and 
more specifically the ultrasound (US) 
and magnetic resonance imaging (MRI) 
findings at various stages of the natural 
history of this condition. Investigation 
of RA using the standard techniques of 
plain radiography (x-ray) and more so-
phisticated computerised tomography 
(CT) have now been superseded by the 
exponential growth of use of US and 
MRI and this has been born out by the 
profusion of scientific papers published 
on these subjects. 
This paper aims to review the array 
of imaging modalities available as in-
vestigative tools to the rheumatologist 
when presented with various clinical 
scenarios by patients with RA.
Introduction
The field of inflammatory arthritis 
owes much to the advances in imaging 
technology which have enlightened 
not only clinical specialists but also re-
searchers worldwide. The most exciting 
developments in recent decades have 
centred upon rheumatoid arthritis (RA) 
and more specifically the ultrasound 
(US) and magnetic resonance imag-
ing (MRI) findings at various stages 
of the natural history of this condition. 
Investigation of RA using the standard 
techniques of plain radiography (x-ray) 
and more sophisticated computerised 
tomography (CT) have now been su-
perseded by the exponential growth of 
use of US and MRI and this has been 
born out by the profusion of scientific 
papers published on these subjects. 
The necessary elements which any im-
aging tool must possess to be consid-
ered a robust method of investigation 
in RA include: low cost, minimal risk 
to patient safety, reproducibility and 
sensitivity to change longitudinally.
This paper aims to review the array 
of imaging modalities available as in-
vestigative tools to the rheumatologist 
when presented with various clinical 
scenarios by patients with RA.
Plain radiography
X-ray investigation in RA can docu-
ment a wide range of changes accord-
ing to the stage of the illness and the 
degree of severity. In the hands the 
pattern of involvement includes the 
metacarpo-phalangeal (MCP), proxi-
mal inter-phalangeal (PIP) and carpal 
joints. In the early stages, the plain x-
ray findings can be subtle and include 
soft tissue shadowing around inflamed 
joints particularly in the hands and feet. 
Juxta-articular osteopenia may be seen 
as the inflammatory process progress-
es, indicative of a hypermetabolic state 
in the region joint inflammation (1, 2). 
Often this is followed by loss of joint 
space linked with focal eburnation of 
articular cartilage. One of the hall-
mark features of RA, bone erosion, is 
a pathognomonic radiographic feature 
which heralds a poorer prognosis for 
the patient and functional impairment 
(3, 4). The presence of joint erosion in 
early RA is a strong indicator of persist-
ence of an active inflammatory process 
and is a useful guide to the rheumatolo-
gist when treatment options are being 
considered. It has been demonstrated 
by several researchers that compared to 
other imaging modalities, e.g. US and 
MRI, x-ray is an insensitive tool for 
detection of erosion in the early stages 
of RA (5-8). 
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The advance of RA in any one patient 
may vary between joints and is often 
non-linear in any single joint (9). The 
condition also has well documented 
soft tissue involvement which is not 
well visualised by x-ray and contributes 
significantly to the clinical presentation 
at all stages of the disease (10). Whilst 
x-rays are standardly performed in all 
patients with newly diagnosed RA it 
would appear that the findings are un-
able to predict overall functional status 
(11). In later disease, however, the de-
gree of bony involvement is more inti-
mately linked with functional level and 
degree of disability.
To many clinicians, plain x-ray remains 
the sole method of charting progres-
sion of RA (12). X-ray has several ad-
vantages including relatively low cost, 
widespread availability and reproduci-
bility. There are caveats to this imaging 
doctrine including the insensitivity to 
identification of erosion and the paucity 
of information gathered about soft tis-
sue pathology. The majority of clinical 
trials in RA employ validated scoring 
methods all of which concentrate on 
the characteristic features of RA (13-
15). These methods are predominantly 
used within the research arena as they 
tend to be impractical for everyday use 
in clinical practice. 
Computerised tomography 
Computerised tomography (CT) scan-
ning is rarely used in clinical practice 
to image patients with RA. Its capabili-
ties do extend however to the accurate 
detection of bony erosions in RA and 
it has been shown to be more sensitive 
than MRI by some investigators (16-
20). Some studies in RA have used CT 
as a gold standard reference tool for 
bone erosion quantification when com-
pared with other imaging modalities. 
It is not a sensitive method for demon-
strating changes in soft tissues and is 
therefore inferior to both US and MRI 
(21). Currently the relatively limited 
access to musculoskeletal CT coupled 
with its inherent limitations relating 
to soft tissue pathology, renders this 
particular mode of imaging an improb-
able candidate for further clinical use 
in RA.
Magnetic resonance imaging 
The merits of using magnetic reso-
nance imaging (MRI) in RA have been 
widely documented in the literature. It 
not only clearly demonstrates soft tis-
sue changes within synovium and sur-
rounding tissue but also erosive bony 
changes. There is excellent correlation 
between histomorphic changes within 
inflamed joints in RA and the MRI 
findings (22, 23). In addition MRI can 
detect oedematous change within bone 
marrow which appears to herald incipi-
ent bone erosion and therefore it is an 
impressive modality for predicting out-
come in RA (24).
MRI scanning in RA requires enhance-
ment with intravenous gadolinium to 
demonstrate synovitis and therefore 
standardly a pre- and post- gadolinium 
enhancement T-weighted scan is per-
formed together with a T2-weighted fat 
saturated sequence to permit accurate 
description of bone oedema and erosive 
change, if present. The Outcome Meas-
ures in Rheumatology (OMERACT) 
group have adopted MRI for an inter-
nationally validated semi-quantitative 
scoring system for bone changes in RA 
(RAMRIS) (25). This system has been 
shown to be sensitive to change at all 
stages of the disease particularly in re-
lation to progression of erosive changes 
when compared to plain x-ray (26, 27).
Several studies have investigated the 
prognostic potential of MRI in early 
RA. Whilst the earliest changes seen 
with MRI such as bone oedema and 
synovitis may not be specific to RA 
when compared to other inflammatory 
arthritides. Baseline findings on MRI 
appear to correlate well with the preva-
lence of erosions in both short term and 
longer term follow-up in RA (28-30).
The field of MRI development is cer-
tainly not a static environment and 
several innovations have recently been 
suggested which will impact favourably 
on patients with RA including newer 
contrast agents which will concentrate 
within the synovium for longer periods 
to allow multiple joint assessment to 
be performed in the same session and 
the use of total body MRI as a tool for 
targeting investigation at the most bio-
logically active joints in RA (31, 32).
In spite of the impressive qualities of 
MRI in imaging RA the method does 
have certain important drawbacks. 
These include limited access to scanners 
in some centres together with the cost 
and impracticalities of using it to be a 
feasible follow-up imaging tool in RA.
Ultrasound 
Much has been written about the use 
of ultrasound (US) in RA in recent 
decades (33-35). Interest has gath-
ered in momentum as rheumatologists 
have increasingly been introducing 
this modality into their daily routine 
clinical practice as a tool to diagnose, 
aid therapeutic intervention and moni-
tor disease progression (36, 37). High 
frequency US provides many of the 
desirable qualities for an imaging tool 
in RA including accurate depiction of 
both soft tissue and bony changes at all 
stages of the disease process, dynamic 
capabilities, lack of radiation exposure, 
reproducibility and relatively low cost. 
Opponents to the diffusion of US in the 
hands of rheumatologists themselves 
have made much of the steep ascent 
of the US skills learning curve and the 
anatomical barriers which exist within 
some joints limiting its use.
US is able to detect a panoply of mor-
phostructural changes in RA. These in-
clude inflammation of synovial tissue 
within joints and adjacent peri-articular 
structures using both grey scale and 
power Doppler modes (38-40). Bone 
erosion in RA is well visualised, even 
at microscopic level (<1mm diameter). 
US performs better than plain x-ray in 
its yield of erosions but appears to be 
slightly less sensitive than MRI in this 
respect (41-43). No currently validated 
system for assessing joints in RA exists 
although several have been suggested 
by various investigators. A systematic 
approach is most often adopted and tai-
lored to the examination of the joints 
which are symptomatic and those which 
are most commonly targeted by RA. 
Currently, there are limited longitudinal 
data available concerning the link be-
tween baseline US findings in patients 
with RA and subsequent functional 
outcomes. In short term follow-up 
studies, however, there would appear 
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to be a correlation between the degree 
of synovial inflammation as docu-
mented by grey scale/ power Doppler 
and subsequent disease activity and ra-
diographic change (44, 45, 48, 49). It 
has been reported that low grade, sub-
clinical synovitis can be detected in RA 
patients whose disease activity score 
(DAS) indicates clinical remission.
Several investigators have employed 
US as a therapeutic monitoring tool in 
RA (46-48). These studies have concen-
trated both on local joint injection ther-
apies and more latterly with systemic 
immunosuppressive therapy including 
biologic agents. Results have been var-
iable but do suggest that US may be-
come a valuable method of monitoring 
RA. Its role in influencing management 
decisions by the rheumatologist has yet 
to be investigated. 
The role of US in RA is now well em-
bedded in routine rheumatological prac-
tice and likely to benefit further from the 
advances which are continually emerg-
ing within the realms of US technology. 
The advent of three-dimensional (3D) 
US promises to deliver solutions to the 
lengthy practical skills acquisition proc-
ess necessary to perform conventional 
US (50). The most recent development 
in US is termed ‘Fusion Imaging’ (com-
bining US imagery with MRI or CT 
contemporaneously) which improves 
diagnostic accuracy by generating im-
agery which expands on the individual 
accuracy of each modality (32).
The future of imaging in RA appears 
bright and likely to continue to guide 
rheumatological management of this 
debilitating form of arthritis.
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